![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Tools
Tools
Preview |
PDF (Original Article)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
994kB |
![[thumbnail of Supplementary Data]](https://edoc.mdc-berlin.de/style/images/fileicons/other.png) |
Other (Supplementary Data)
12MB |
| Item Type: | Article |
|---|---|
| Title: | Targeting RUNX1 protects against diastolic dysfunction in a two-hit mouse model of heart failure with preserved ejection fraction |
| Creators: |
Elbassioni, Ali Ali Mohamed  ORCID: https://orcid.org/0000-0003-2641-2460, Raheem, Anmar A. ORCID: https://orcid.org/0000-0002-6233-6218, Song, Jian, Johnston, Alexander S., Trivett, Cara, Lin, Hong, Zhang, Haobo, Bradley, Ashley, Higgins, Erin, Thomson, Cameron R., Mooney, Leanne, Koay, Yen Chin, O'Toole, Dylan, Herzyk, Pawel, Nixon, Colin, Blyth, Karen, Hughes, Mark, Nawwar, Al-Attar, O'Sullivan, John F., Lang, Ninian N. ORCID: https://orcid.org/0000-0001-8441-6887, Berry, Colin ORCID: https://orcid.org/0000-0002-4547-8636, Braun, Thomas ORCID: https://orcid.org/0000-0002-6165-4804, Schiattarella, Gabriele G. ORCID: https://orcid.org/0000-0002-7582-7171, Giacca, Mauro ORCID: https://orcid.org/0000-0003-2927-7225, McBride, Martin W., Nicklin, Stuart A., Cameron, Ewan R., Loughrey, Christopher M. ORCID: https://orcid.org/0000-0003-1297-9159 and MacDonald, Eilidh A. ORCID: https://orcid.org/0000-0002-7771-754X
|
| Abstract: | AIMS: Heart failure with preserved ejection fraction (HFpEF) continues to increase in prevalence and has limited treatment options. HFpEF is a systemic condition with a broad phenotype including diastolic dysfunction, pulmonary oedema, exercise intolerance, and left ventricular (LV) hypertrophy, collectively resulting in enhanced morbidity and mortality. The transcription factor RUNX1 has recently been identified as a mediator of pathological changes in multiple cardiac diseases, however its role in HFpEF remained unknown. METHODS AND RESULTS: Here we show that inhibition of Runx1 limits adverse cardiac remodelling in a clinically relevant mouse model of HFpEF. Cardiomyocyte-specific tamoxifen-inducible Runx1-deficient mice with HFpEF are protected, with preservation of diastolic function, and attenuation of pulmonary oedema, exercise intolerance, and hypertrophy. Furthermore, targeting Runx1 in HFpEF by using gene transfer or small molecule inhibitor Ro5-3335 improves diastolic function and reduces pulmonary oedema, both in female and male mice. CONCLUSION: Overall, our research enhances our understanding of RUNX1 in cardiac disease and presents a novel translational target for the treatment of HFpEF. |
| Keywords: | Heart Failure with Preserved Ejection Fraction, Metabolic Heart Failure, Diastolic Dysfunction, Hypertrophy, Pulmonary Oedema, Exercise Intolerance, Animals, Mice |
| Source: | Cardiovascular Research |
| ISSN: | 0008-6363 |
| Publisher: | Oxford University Press / European Society of Cardiology |
| Volume: | 122 |
| Number: | 10 |
| Page Range: | 1318-1328 |
| Date: | July 2026 |
| Official Publication: | https://doi.org/10.1093/cvr/cvag106 |
| PubMed: | View item in PubMed |
Repository Staff Only: item control page
